Latest news
2019-08-26
Camurus’ treatment Buvidal® subsidised in Australia
Australia has announced that Camurus’ treatment Buvidal® (buprenorphine) will be listed through the Pharmaceutical B…
Read more
2019-08-07
Three new products from ISEC
ISEC has launched three new products for better and safer surveillance of radioactive environments.
Read more
2019-07-23
Positive outcome for Camurus in court proceedings regarding final approval of Brixadi™ in the US
Camurus’ partner Braeburn have received a positive outcome in the US court proceedings which were initiated in April…
Read more
2019-06-20
FDA grants Camurus IND application to enter Phase 3 study with CAM2029 for treatment of acromegaly
The FDA has approved Camurus’ Investigational New Drug application to initiate a Phase 3 study with CAM2029 once-mon…
Read more
2019-06-17
Introducing the chemical-free office
Starting June 2019, all Sandberg Development's office and production facilities will be cleaned and washed with DIRO…
Read more